CAAC Co-Chair of BOT and Membership Review Committee
Lei
Xiao, MD, PhD
Assistant Professor of Medicine (Tenure-Track)
Director for Research Education (Section
of PCCSA)
Department of Medicine & Center for Cardiovascular Research
University of Illinois at Chicago, College of Medicine
840 S Wood St, M/C: 719
Chicago, IL 60612
Dr.
Lei Xiao graduated from Peking University Health Science Center (Beijing,
China) in 1993 with a major in Clinical Medicine. He received his Ph.D. in
Pharmacology from Creighton University School of Medicine (Omaha, NE) in 1998,
where he first cloned the mouse α1A-adrenergic receptor gene during
his Ph.D. studies. In June 2001, he completed his postdoctoral fellow training
in cardiovascular diseases in the Division of Cardiology at Boston University
School of Medicine (Boston, MA), where he then stayed on faculty, and soon became
an Assistant Professor of Medicine in Division of Cardiology. In 2004, Dr. Xiao
relocated his lab to the University of Illinois at Chicago (UIC, Chicago, IL),
and joined in the Department of Medicine (Sections of Pulmonary, Critical Care,
Sleep and Allergy; & Cardiology), and the Center for Cardiovascular
Diseases.
Currently,
Dr. Xiao is a tenure-track Assistant Professor of Medicine at UIC. He is also
the Director for Research Education in the Section of PCCSA, and is the Principle
Investigator (PI) of two NIH R01 grants, one American Heart Association (AHA)
National Scientist Development Grant (NSDG), and several other intramural
research grants. He is also the Co-investigator of three NIH R01 grants and
three NIH S10 grants with other PI's. The research interests of Dr. Xiao's lab
focus on the role of NADPH oxidase and reactive oxygen species in cardiac
hypertrophy and heart failure, as well as the signal transduction pathways in
cardiac myocytes and macrophages.
Dr. Xiao has received over 15 national and international awards for his
research achievement. In 1999 and 2000, he received the First Place Award
two years in a row at the annual AstraZeneca New England Cardiovascular
Research Competition. In 2001, he was awarded the prestigious Jay N. Cohn
New Investigator Award from the Heart Failure Society of America
(HFSA). He is a member of the AHA and the American Society for Pharmacology
& Experimental Therapeutics (ASPET), and received the BCVS Travel Grant
Award from the AHA Council on Basic Cardiovascular Sciences (BCVS) in 2011.
Dr. Xiao has served as an editor or a reviewer for 17 academic journals including
Circulation and Circ. Res., and also as a study section member or
grant reviewer for multiple research funding agencies including Veterans
Affairs (VA) Merit Grant Review Cardiovascular Study Section.
ten Selected Journal Articles (From Over 80
Publications):
1. Liu Y, Lou
YQ, Liu K, Liu JL, Wang ZG, Wen J, Zhao Q,
Wen SJ, Xiao L: Role of Leptin receptor gene polymorphisms in
susceptibility to the development of essential hypertension: a case-control
association study in a Northern Han Chinese population. J Hum Hypertens,
doi:10.1038/jhh.2013.149, Epub Feb. 13, 2014. PMID: 24522342
2. DeSantiago J, Bare
DJ, Xiao L, Ke Y, Solaro RJ, Banach K. p21-Activated kinase1 (Pak1) is a
negative regulator of NADPH-oxidase 2 in ventricular myocytes. J. Mol. Cell.
Cardiol. 67:77-85, 2014. PMID:
24380729
3.Sovari AA, Rutledge
CA, Jeong EM, Dolmatova E, Arasu D, Liu H, Vahdani N, Gu L, Zandieh S, Xiao L,
Bonini MG, Duffy HS, Dudley SC: Mitochondria oxidative stress, connexin43
remodeling, and sudden arrhythmic death, Circ Arrhythm Electrophysiol, 6:623-631,
2013. PMID: 23559673
4.Zhao G, Yu R, Deng J,
Zhao Q, Christman JW, van
Breemen RB,
Xiao L:
Pivotal role of reactive oxygen species in regulating
lipopolysaccharide-induced prostaglandin D2 production in
macrophages. Mol
Pharmacol,
83(1):167-78, 2013. PMID: 23071105
5. Xiao
L, Zhao Q, Du Y, Chao Y, Solaro RJ, Buttrick PM: PKCε increases
phosphorylation of cardiac myosin binding protein C at serine302 both in
vitro and in vivo. Biochemistry 46(23):7054-7061, 2007
6. Maytin
M, Siwik DA, Ito M, Xiao L, Sawyer DB, Liao R, Colucci WS.: Pressure
overload-induced myocardial hypertrophy in mice does not require gp91phox.
Circulation 109(9):1168-71, 2004.
7. Xiao
L, Pimentel DR, Wang J, Singh K, Colucci WS, Sawyer DB: Role of reactive
oxygen species and NAD(P)H oxidase in α1-adrenoceptor signaling
in adult rat cardiac myocytes. Am J Physiol Cell Physiol, 282:C926-C934,
2002.
8. Xiao
L., Pimental D.R., Amin J.K., Singh K., Sawyer D.B., Colucci W.S.:
MEK1/2-ERK1/2 mediates α1-adrenergic receptor stimulated
hypertrophy in adult rat ventricular myocytes. J. Mol. Cell. Cardiol.
33:779-787, 2001.
9. Amin
JK, Xiao L, Pimental DR, Patrick PJ, Sawyer DB, Colucci WS: Reactive
oxygen species mediate alpha-adrenergic receptor-stimulated hypertrophy in
adult rat ventricular myocytes. J. Mol. Cell. Cardiol. 33:131-139, 2001.
10. Pimentel
DR, Amin JK, Xiao L, Miller T, Viereck J, Oliver-Krasinski J, Baliga R,
Wang J, Siwik DA, Singh K, Pagano P, Colucci WS, Sawyer DB: Reactive oxygen
species mediate amplitude-dependent hypertrophic and apoptotic responses to
mechanical stretch in cardiac myocytes. Circ. Res. 89:453-460, 2001.